홈 › 버킷 림프종 › 플로리다

플로리다의 버킷 림프종 임상 시험

버킷 림프종 관련 연구 15개가 플로리다 내 여러 지역에서 참여자를 모집하고 있습니다.

플로리다의 도시

공식 연구 텍스트(영어)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
외 9개

피험자 모집 중2상

366 Days – 46 Years · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
Orlando Health Cancer Institute, Orlando

피험자 모집 중3상

18세 ~ 39세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT03150693

Blinatumomab Consolidation in Real World

Mayo Clinic Cancer Center, Jacksonville

피험자 모집 중관찰 연구건강한 지원자 환영

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07117136

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Jupiter Medical Center, Jupiter

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT03739814

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Moffitt Cancer Center, Tampa

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06144606

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
Nemours Children's Clinic-Jacksonville, Jacksonville
외 8개

피험자 모집 중2상

365 Days · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

SSAK Partners, Coral Springs
Mayo Clinic - Jacksonville, Jacksonville

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07648264

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg

피험자 모집 중1/2상

6 Months – 25 Years · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06395103

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

H. Lee Moffitt Cancer Center, Tampa

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
외 9개

피험자 모집 중2상

1세 ~ 30세 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Broward Health Medical Center, Fort Lauderdale
Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
외 12개

피험자 모집 중3상

365 Days – 25 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site, Tampa

피험자 모집 중1/2상

12세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT06137118

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Mayo Clinic, Clinical Trials Referral Office, Jacksonville

피험자 모집 중1/2상

13세 ~ 90세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT06533579

Study of SGR-1505 in Mature B-Cell Neoplasms

Napa Research, Pompano Beach

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT05544019

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

University of Florida, Gainesville
Nicklaus Children's Hospital, Miami
Johns Hopkins All Children's Hospital, St. Petersburg

피험자 모집 중2상

1세 ~ 25세 · 모든 성별 · 2025. 5. 4. 업데이트됨 · NCT03509961

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.